Effects of high-speed rotational atherectomy in peripheral artery disease patients with calcified lesions: a retrospecti

  • PDF / 586,493 Bytes
  • 5 Pages / 595.276 x 790.866 pts Page_size
  • 24 Downloads / 181 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

Effects of high‑speed rotational atherectomy in peripheral artery disease patients with calcified lesions: a retrospective multicenter registry Yoshiya Yamamoto1 · Osami Kawarada1,2   · Hiroshi Ando3 · Hitoshi Anzai4 · Kan Zen5 · Kenji Tamura6 · Kengo Tsukahara7 · Yoshinori Tsubakimoto8 · Masanao Toma9 · Shigeru Nakamura10 · Hiroaki Nakamura11 · Koji Hozawa12 · Yoshiaki Yokoi13 · Satoshi Yasuda1 Received: 7 September 2019 / Accepted: 17 January 2020 © Japanese Association of Cardiovascular Intervention and Therapeutics 2020

Abstract Calcified lesions still remain a technical challenge even in the treatment of infrainguinal artery disease. The aim of this retrospective, multicenter observational study was to investigate interventional outcomes of a high-speed rotational atherectomy device (Rotablator™) and to compare clinical outcomes in patients who underwent Rotablator and those who did not even after failed balloon angioplasty because of underlying calcified lesions. This study enrolled patients who underwent Rotablator (Rota group) and those who did not (Non-rota group) between January 2010 and 2014 December at 12 hospitals. A total of 67 limbs and 68 lesions in 65 patients were included (Rota group; 54 limbs and 55 lesions in 52 patients, Non-rota group; 13 limbs and 13 lesions in 13 patients). In the Rota group, a technical success rate was 94.5% with a complication rate of 1.8%, and all lesions underwent subsequent postdilatation following the adjunctive use of Rotablator, and approximately half of above-the-knee lesions underwent stent implantation. The Rota group had a significantly lower clinically driven reintervention rate at 12 months than the Non-rota group (26.5% vs. 58.3%, respectively, p = 0.046). In addition, Rota group showed a trend toward a higher amputation-free survival compared to the Non-rota group at 1 month (Rota; 98.0% vs. Non-rota; 84.6%, respectively, p = 0.10). Rotablator was used as an adjunctive device with a high technical success and a low complication rates, and Patients who underwent Rotablator yielded a significantly lower clinically driven reintervention rate at 12 months compared to those who did not even after failed balloon angioplasty. Keywords  Rotablator · Peripheral artery disease · Calcification

7



Department of Cardiology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan

8



Department of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Kyoto, Japan

9



Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan

10

Department of Cardiology, Kasukabe Chuo General Hospital, Kasukabe, Saitama, Japan

Department of Cardiology, Kyoto Katsura Hospital, Kyoto, Kyoto, Japan

11

Department of Cardiology, Ota Memorial Hospital, Ota, Gunma, Japan

Department of Cardiology, Kakogawa East City Hospital, Kakogawa, Hyogo, Japan

12

Department of Cardiology, Omihachiman Community Medical Center, Omihachiman, Shiga, Japan

Department of Cardiology, New Tokyo Hospital, Matsudo, Chiba, Japa